Thermo Fisher Scientific and Cerilliant Corporation to Offer Certified Solution Standards for Forensic and Clinical Research Laboratories
News Jan 06, 2010
Scientists performing drugs of abuse analysis in forensic and clinical research laboratories currently face challenges because a large number of different testing methods are used within the industry with no standardization on reagents. Cerilliant's certified Snap-N-SpikeT/ Snap-N-Shoot® solutions for the ToxSpec Analyzer offer the industry standardized solutions that are performance tested for reliability and effectiveness. Cerilliant is a global leader in providing analytical reference standards and controls to the analytical community. The company pioneered the development of ready-to-use, solution-based reference standards provided in a shelf-stable, efficient and accurate format suitable for quantitative applications.
The ToxSpec Analyzer comprises integrated software, hardware and methodologies for forensic toxicology and simplifies the process of running assays while reducing analysis time and increasing confidence in compound identification. This new collaboration will facilitate the development of analytical methodologies designed to meet clinical research and forensic toxicology laboratories' increasingly strict regulatory requirements as well as the need to process assays in a much shorter space of time. The certified solution standards come with complete certificates of analysis and require no preparation or testing, resulting in accelerated turn-around times and significant savings.
Cell Recycling System Offers Therapeutic Entry Point for Rare Disease TreatmentNews
Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).READ MORE
Cancer Cells Force Normal Cells to Act Like Viruses, Helping Tumors SpreadNews
Researchers reveal how cancer cells force normal cells to act like viruses – allowing tumors to grow, resist treatment, and spread.READ MORE
Edith Heard Unanimously Selected as Next Director General of EMBLNews
At its 53rd meeting yesterday, EMBL Council selected Edith Heard as the organization’s fifth Director General. Heard’s mandate is scheduled to begin 1 January 2019.READ MORE
Comments | 0 ADD COMMENT
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018
EMBL Course: Target Engagement in Biology and Drug Discovery
Feb 19 - Feb 23, 2018